Note 9 - Segment Information

6 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

9

. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company

’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing,

Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

December 31, 2017

and

2016

were

$1,248

and

$1,797,

respectively, and for the

six

months ended

December 31, 2017

and

2016

were

$2,906

and

$4,673,

respectively.

Financial information relating to the

three

months ended

December 31, 2017

and

2016

operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit (Loss)		Depreciatio n		Expenditures
Contract	2017	$	9,159	$	1,199	$	10,358	$	896	$	55	$	109
Manufacturing	2016		10,207		1,687		11,894		1,344		80		42
Branded Proprietary	2017		162		10		172		65		1		-
Products	2016		61		101		162		17		-		-
Other Nutraceutical	2017		231		39		270		87		1		-
Businesses	2016		307		9		316		109		-		-
Total	2017		9,552		1,248		10,800		1,048		57		109
Company	2016		10,575		1,797		12,372		1,470		80		42

Financial

information relating to the

six

months ended

December 31, 2017

and

2016

operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit (Loss)		Depreciation		Expenditures
Contract	2017	$	16,981	$	2,782	$	19,763	$	1,731	$	129	$	202
Manufacturing	2016		19,528		4,398		23,926		3,240		151		83
Branded Proprietary	2017		181		21		202		97		2		13
Products	2016		90		196		286		51		-		-
Other Nutraceutical	2017		502		103		605		225		1		1
Businesses	2016		762		79		841		330		1		1
Total	2017		17,664		2,906		20,570		2,053		132		216
Company	2016		20,380		4,673		25,053		3,621		152		84

	Total Assets as of
	December 31,		June 30,
	2017		2017
Contract Manufacturing	$	13,154	$	12,134
Branded Proprietary Products		710		784
Other Nutraceutical Businesses		1,784		2,278
Total Company	$	15,648	$	15,196